Modified Dose Intensive R- CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048) Shows Efficacy and Tolerability, and Predictive Potential of IRF4/MUM1 Expression

Infectious Agents and Cancer - United Kingdom
doi 10.1186/1750-9378-7-s1-o14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search